Log In
Print
BCIQ
Print
Print this Print this
 

Banzel, Inovelon, rufinamide (Banzel oral suspension) (E2080)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionTriazole derivative
Molecular Target Sodium channel
Mechanism of Action 
Latest Stage of DevelopmentMarketed
IndicationLennox-Gastaut syndrome
Partner

Eisai Co. Ltd.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today